Access Guide · Updated May 2026

GLP-1 Medications Without Insurance: Every Option Available in 2026

May 2026  |  BetterNewLives.com

Going without insurance — or having insurance that won't cover GLP-1 medications — does not mean paying $900–$1,400/month. Most people in this situation have at least two or three meaningful options they haven't explored. This guide walks through all of them in order of cost, so you can find the best path for your situation.

Start here: your income level changes everything If your household income is at or below approximately 400–600% of the federal poverty level, you may qualify for free medication through manufacturer patient assistance programs. Check this first before spending anything. See our full savings guide for program details.

All Options, Ordered by Monthly Cost

OptionMonthly CostMedicationRequires Rx?Medical Oversight?
Patient assistance (Lilly Cares / Novo Nordisk PAP) $0 (if eligible) Brand-name Mounjaro, Wegovy, etc. Yes Yes (through prescriber)
Telehealth program — semaglutide entry ~$99–$149/mo Compounded semaglutide Yes (included) Yes (included)
Telehealth program — semaglutide standard $149–$299/mo Compounded semaglutide Yes (included) Yes (included)
Telehealth program — tirzepatide entry ~$199/mo Compounded tirzepatide Yes (included) Yes (included)
Telehealth program — tirzepatide standard $299–$499/mo Compounded tirzepatide Yes (included) Yes (included)
Brand-name (full list price, no savings card) $900–$1,400/mo Ozempic / Wegovy / Mounjaro / Zepbound Yes Yes (through prescriber)

Option 1: Patient Assistance Programs — Potentially Free

1
Manufacturer Patient Assistance Programs
$0 if eligible
Who it's for: Uninsured or underinsured patients with income need

Both Eli Lilly (Lilly Cares Foundation) and Novo Nordisk (NovoCare PAP) operate programs that can provide brand-name GLP-1 medications at no cost to qualifying patients. Income thresholds vary but generally reach patients earning up to 400–600% of the federal poverty level — covering a broader range of middle-income households than many people expect.

This is the single most overlooked option for uninsured patients. Many people assume they earn too much to qualify, or don't know the programs exist. It takes 15–30 minutes to check eligibility online and costs nothing to apply.

Action: See our complete savings and assistance guide for step-by-step application details for both programs.

Option 2: Telehealth Programs — $99–$499/Month

2
Telehealth Programs with Compounded Medication
$99–$499/mo
Who it's for: Patients who don't qualify for free assistance programs

For patients who don't qualify for patient assistance, telehealth programs using compounded semaglutide or tirzepatide represent the most accessible paid option. These programs bundle everything: a virtual medical consultation, a prescription, the compounded medication shipped to your door, and ongoing clinical support — for a flat monthly fee that is 60–80% less than brand-name list price.

Semaglutide programs

Entry-level semaglutide programs start around $99/month (Found) and $149/month (Hims & Hers, Noom Med). Standard dosing programs run $149–$299/month. Henry Meds offers a flat $297/month regardless of dose. Compare them all on our semaglutide program comparison page.

Tirzepatide programs

Tirzepatide programs start around $199/month (Henry Meds) and run up to $499/month (Eden) for premium clinical management programs. Tirzepatide generally costs $50–$100/month more than equivalent semaglutide programs due to higher API costs. Compare them on our tirzepatide program comparison page.

What to watch for

  • Confirm the pharmacy is a 503B outsourcing facility — not all programs use them
  • Ask whether price increases as your dose escalates, or if it's flat-rate
  • Verify what's included: medication, syringes, consultations, ongoing messaging
  • Check that the program is available in your state — not all platforms operate nationwide

Option 3: See If You Qualify for Insurance

3
ACA Marketplace Coverage
Varies by plan
Who it's for: Currently uninsured patients who might qualify for subsidized coverage

If you're currently uninsured, you may qualify for subsidized health insurance through the ACA Marketplace (healthcare.gov) that would cover GLP-1 medications at a copay, potentially for less than a telehealth program. Premium subsidies are available based on income, and many ACA plans have improved GLP-1 formulary coverage since 2024.

Open enrollment typically runs November–January, with Special Enrollment Periods available for qualifying life events. If you're uninsured and considering a $200–$300/month telehealth program, it's worth comparing that cost against an ACA plan that might cover your GLP-1 and provide broader health coverage simultaneously.

Action: Visit healthcare.gov or speak with a licensed insurance navigator (free service in most states) to check current plan options and subsidy eligibility.

What to avoid There are websites and social media accounts selling "GLP-1 peptides" or "semaglutide vials" without requiring a prescription and shipping from overseas or unverified domestic sources. These products have no quality verification, no prescription oversight, and no legal standing under U.S. pharmacy law. The risks — contamination, incorrect dosing, undisclosed ingredients — are meaningful. Stick to licensed telehealth programs with verified U.S.-based compounding pharmacies, or the brand-name products through a licensed prescriber.

What Not to Do

The Full Hub: Everything You Need to Know